Terms: = Endocrine gland cancer AND SDHC, CYBL, 6391, ENSG00000143252, SDH3, PGL3, QPS1, CYB560 AND Diagnosis
43 results:
1. Back to Biochemistry: Evaluation for and Prognostic Significance of SDH Mutations in Paragangliomas and Pheochromocytomas.
Gupta S; Erickson LA
Surg Pathol Clin; 2023 Mar; 16(1):119-129. PubMed ID: 36739159
[TBL] [Abstract] [Full Text] [Related]
2. Case Report: Composite pheochromocytoma with ganglioneuroma component: A report of three cases.
Araujo PB; Carvallo MS; Vidal AP; Nascimento JB; Wo JM; Naliato EO; Cunha Neto SH; Conceição FL; Fontes R; de Lima VV; Carvalho DP; Soares P; Lima J; Lourenço DM; Violante AHD
Front Endocrinol (Lausanne); 2022; 13():903085. PubMed ID: 36187102
[TBL] [Abstract] [Full Text] [Related]
3. Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.
Lamy C; Tissot H; Faron M; Baudin E; Lamartina L; Pradon C; Al Ghuzlan A; Leboulleux S; Perfettini JL; Paci A; Hadoux J; Broutin S
J Clin Endocrinol Metab; 2022 Sep; 107(10):2801-2810. PubMed ID: 35948272
[TBL] [Abstract] [Full Text] [Related]
4. Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours.
Loughrey PB; Roncaroli F; Healy E; Weir P; Basetti M; Casey RT; Hunter SJ; Korbonits M
Endocr Relat Cancer; 2022 Oct; 29(10):R157-R172. PubMed ID: 35938916
[TBL] [Abstract] [Full Text] [Related]
5. sdhc phaeochromocytoma and paraganglioma: A UK-wide case series.
Williams ST; Chatzikyriakou P; Carroll PV; McGowan BM; Velusamy A; White G; Obholzer R; Akker S; Tufton N; Casey RT; Maher ER; Park SM; Porteous M; Dyer R; Tan T; Wernig F; Brady AF; Kosicka-Slawinska M; Whitelaw BC; Dorkins H; Lalloo F; Brennan P; Carlow J; Martin R; Mitchell AL; Harrison R; Hawkes L; Newell-Price J; Kelsall A; Igbokwe R; Adlard J; Schirwani S; Davidson R; Morrison PJ; Chung TT; Bowles C; Izatt L
Clin Endocrinol (Oxf); 2022 Apr; 96(4):499-512. PubMed ID: 34558728
[TBL] [Abstract] [Full Text] [Related]
6. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
[TBL] [Abstract] [Full Text] [Related]
7. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
[TBL] [Abstract] [Full Text] [Related]
8. Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma.
Buffet A; Ben Aim L; Leboulleux S; Drui D; Vezzosi D; Libé R; Ajzenberg C; Bernardeschi D; Cariou B; Chabolle F; Chabre O; Darrouzet V; Delemer B; Desailloud R; Goichot B; Esvant A; Offredo L; Herman P; Laboureau S; Lefebvre H; Pierre P; Raingeard I; Reznik Y; Sadoul JL; Hadoux J; Tabarin A; Tauveron I; Zenaty D; Favier J; Bertherat J; Baudin E; Amar L; Gimenez-Roqueplo AP;
J Clin Endocrinol Metab; 2019 Apr; 104(4):1109-1118. PubMed ID: 30698717
[TBL] [Abstract] [Full Text] [Related]
9. The Role of Immunohistochemistry and Molecular Analysis of Succinate Dehydrogenase in the diagnosis of endocrine and Non-endocrine Tumors and Related Syndromes.
Oudijk L; Gaal J; de Krijger RR
Endocr Pathol; 2019 Mar; 30(1):64-73. PubMed ID: 30421319
[TBL] [Abstract] [Full Text] [Related]
10. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
[TBL] [Abstract] [Full Text] [Related]
11. Routine genetic screening with a multi-gene panel in patients with pheochromocytomas.
Sbardella E; Cranston T; Isidori AM; Shine B; Pal A; Jafar-Mohammadi B; Sadler G; Mihai R; Grossman AB
Endocrine; 2018 Jan; 59(1):175-182. PubMed ID: 28477304
[TBL] [Abstract] [Full Text] [Related]
12. Genotype-phenotype correlation in paediatric pheochromocytoma and paraganglioma: a single centre experience from India.
Khadilkar K; Sarathi V; Kasaliwal R; Pandit R; Goroshi M; Shivane V; Lila A; Bandgar T; Shah NS
J Pediatr Endocrinol Metab; 2017 May; 30(5):575-581. PubMed ID: 28432847
[TBL] [Abstract] [Full Text] [Related]
13. Rapid-sequence MRI for long-term surveillance for paraganglioma and phaeochromocytoma in patients with succinate dehydrogenase mutations.
Daniel E; Jones R; Bull M; Newell-Price J
Eur J Endocrinol; 2016 Dec; 175(6):561-570. PubMed ID: 27634942
[TBL] [Abstract] [Full Text] [Related]
14. A novel RET gene mutation in a patient with apparently sporadic pheochromocytoma.
Scollo C; Russo M; De Gregorio L; Terranova R; Mangione E; Castoro C; Squatrito S; Pellegriti G
Endocr J; 2016; 63(1):87-91. PubMed ID: 26497911
[TBL] [Abstract] [Full Text] [Related]
15. Coexistence of paraganglioma/pheochromocytoma and papillary thyroid carcinoma: a four-case series analysis.
Bugalho MJ; Silva AL; Domingues R
Fam Cancer; 2015 Dec; 14(4):603-7. PubMed ID: 26071763
[TBL] [Abstract] [Full Text] [Related]
16. A registry-based study of thyroid paraganglioma: histological and genetic characteristics.
von Dobschuetz E; Leijon H; Schalin-Jäntti C; Schiavi F; Brauckhoff M; Peczkowska M; Spiazzi G; Demattè S; Cecchini ME; Sartorato P; Krajewska J; Hasse-Lazar K; Roszkowska-Purska K; Taschin E; Malinoc A; Akslen LA; Arola J; Lange D; Fassina A; Pennelli G; Barbareschi M; Luettges J; Prejbisz A; Januszewicz A; Strate T; Bausch B; Castinetti F; Jarzab B; Opocher G; Eng C; Neumann HP
Endocr Relat Cancer; 2015 Apr; 22(2):191-204. PubMed ID: 25595276
[TBL] [Abstract] [Full Text] [Related]
17. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.
Favier J; Amar L; Gimenez-Roqueplo AP
Nat Rev Endocrinol; 2015 Feb; 11(2):101-11. PubMed ID: 25385035
[TBL] [Abstract] [Full Text] [Related]
18. Role of 18F-DOPA PET/CT in diagnosis and follow-up of adrenal and extra-adrenal paragangliomas.
Bacca A; Chiacchio S; Zampa V; Carrara D; Duce V; Congregati C; Simi P; Taddei S; Materazzi G; Volterrani D; Mariani G; Bernini G
Clin Nucl Med; 2014 Jan; 39(1):14-20. PubMed ID: 24300347
[TBL] [Abstract] [Full Text] [Related]
19. Long-term prognosis of patients with pediatric pheochromocytoma.
Bausch B; Wellner U; Bausch D; Schiavi F; Barontini M; Sanso G; Walz MK; Peczkowska M; Weryha G; Dall'igna P; Cecchetto G; Bisogno G; Moeller LC; Bockenhauer D; Patocs A; Rácz K; Zabolotnyi D; Yaremchuk S; Dzivite-Krisane I; Castinetti F; Taieb D; Malinoc A; von Dobschuetz E; Roessler J; Schmid KW; Opocher G; Eng C; Neumann HP
Endocr Relat Cancer; 2014 Feb; 21(1):17-25. PubMed ID: 24169644
[TBL] [Abstract] [Full Text] [Related]
20. Whole exome sequencing is an efficient and sensitive method for detection of germline mutations in patients with phaeochromcytomas and paragangliomas.
McInerney-Leo AM; Marshall MS; Gardiner B; Benn DE; McFarlane J; Robinson BG; Brown MA; Leo PJ; Clifton-Bligh RJ; Duncan EL
Clin Endocrinol (Oxf); 2014 Jan; 80(1):25-33. PubMed ID: 24102379
[TBL] [Abstract] [Full Text] [Related]
[Next]
